This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-19a-3p | ABCA1 | 2.12 | 0 | -0.92 | 1.0E-5 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.16 | 0 | 27445062 | The target genes of miR-19a such as ABCA1 and PTEN that had been suppressed by miR recovered their expression through CAP treatment |
2 | hsa-miR-19a-3p | ABCD3 | 2.12 | 0 | -0.14 | 0.33401 | MirTarget | -0.11 | 0 | NA | |
3 | hsa-miR-19a-3p | ABHD2 | 2.12 | 0 | -0.74 | 0.00059 | mirMAP | -0.13 | 8.0E-5 | NA | |
4 | hsa-miR-19a-3p | ACSL4 | 2.12 | 0 | -1.28 | 0 | MirTarget; miRNATAP | -0.23 | 0 | NA | |
5 | hsa-miR-19a-3p | ADAMTSL3 | 2.12 | 0 | -3.15 | 0 | miRNATAP | -0.29 | 0 | NA | |
6 | hsa-miR-19a-3p | ADARB1 | 2.12 | 0 | -1.88 | 0 | mirMAP | -0.11 | 0.00084 | NA | |
7 | hsa-miR-19a-3p | ADCY9 | 2.12 | 0 | -1.41 | 0 | miRNATAP | -0.19 | 0 | NA | |
8 | hsa-miR-19a-3p | AFF2 | 2.12 | 0 | -2.23 | 0 | mirMAP | -0.17 | 0.02002 | NA | |
9 | hsa-miR-19a-3p | AKAP2 | 2.12 | 0 | -2.97 | 0 | mirMAP | -0.25 | 0 | NA | |
10 | hsa-miR-19a-3p | ANO1 | 2.12 | 0 | -0.71 | 0.02851 | MirTarget; miRNATAP | -0.2 | 8.0E-5 | NA | |
11 | hsa-miR-19a-3p | ANTXR1 | 2.12 | 0 | -0.82 | 0.00129 | MirTarget; mirMAP | -0.27 | 0 | NA | |
12 | hsa-miR-19a-3p | AR | 2.12 | 0 | -1.82 | 6.0E-5 | mirMAP | -0.33 | 0 | NA | |
13 | hsa-miR-19a-3p | ARAP2 | 2.12 | 0 | -1.25 | 0 | MirTarget | -0.17 | 0 | NA | |
14 | hsa-miR-19a-3p | ARC | 2.12 | 0 | -3.69 | 0 | miRNATAP | -0.17 | 0.0115 | NA | |
15 | hsa-miR-19a-3p | ARHGEF12 | 2.12 | 0 | -0.37 | 0.00513 | MirTarget; mirMAP; miRNATAP | -0.1 | 0 | NA | |
16 | hsa-miR-19a-3p | ARID5B | 2.12 | 0 | -0.45 | 0.00256 | miRNATAP | -0.15 | 0 | NA | |
17 | hsa-miR-19a-3p | ARL10 | 2.12 | 0 | -0.26 | 0.31668 | mirMAP | -0.12 | 0.0037 | NA | |
18 | hsa-miR-19a-3p | ARRDC3 | 2.12 | 0 | -0.37 | 0.08066 | MirTarget; miRNATAP | -0.19 | 0 | NA | |
19 | hsa-miR-19a-3p | ARRDC4 | 2.12 | 0 | -1.29 | 0 | MirTarget; miRNATAP | -0.23 | 0 | NA | |
20 | hsa-miR-19a-3p | ASXL2 | 2.12 | 0 | -0.3 | 0.12837 | MirTarget; miRNATAP | -0.14 | 1.0E-5 | NA | |
21 | hsa-miR-19a-3p | ATL3 | 2.12 | 0 | 0.11 | 0.46975 | mirMAP | -0.15 | 0 | NA | |
22 | hsa-miR-19a-3p | ATP10A | 2.12 | 0 | -1.58 | 0 | MirTarget | -0.33 | 0 | NA | |
23 | hsa-miR-19a-3p | ATP1A2 | 2.12 | 0 | -3.15 | 0 | MirTarget | -0.37 | 0 | NA | |
24 | hsa-miR-19a-3p | ATP6V0E1 | 2.12 | 0 | -0.18 | 0.15468 | MirTarget | -0.11 | 0 | NA | |
25 | hsa-miR-19a-3p | ATP6V1B2 | 2.12 | 0 | -0.66 | 0 | MirTarget; miRNATAP | -0.13 | 0 | NA | |
26 | hsa-miR-19a-3p | ATP8A2 | 2.12 | 0 | -2 | 0 | mirMAP | -0.28 | 4.0E-5 | NA | |
27 | hsa-miR-19a-3p | ATRX | 2.12 | 0 | -0.09 | 0.47606 | MirTarget; miRNATAP | -0.11 | 0 | NA | |
28 | hsa-miR-19a-3p | ATXN1 | 2.12 | 0 | -0.47 | 0.0003 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.13 | 0 | NA | |
29 | hsa-miR-19a-3p | ATXN1L | 2.12 | 0 | -0.66 | 0 | miRNATAP | -0.11 | 0 | NA | |
30 | hsa-miR-19a-3p | BBX | 2.12 | 0 | -0.3 | 0.02503 | MirTarget; miRNATAP | -0.11 | 0 | NA | |
31 | hsa-miR-19a-3p | BCAT1 | 2.12 | 0 | -0.21 | 0.54581 | MirTarget; mirMAP | -0.19 | 0.00078 | NA | |
32 | hsa-miR-19a-3p | BMP3 | 2.12 | 0 | -1.37 | 0.01092 | MirTarget | -0.38 | 1.0E-5 | NA | |
33 | hsa-miR-19a-3p | BMPER | 2.12 | 0 | -3.66 | 0 | miRNATAP | -0.27 | 0.00037 | NA | |
34 | hsa-miR-19a-3p | BMPR2 | 2.12 | 0 | -1.25 | 0 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.19 | 0 | NA | |
35 | hsa-miR-19a-3p | BNC2 | 2.12 | 0 | -1.12 | 1.0E-5 | MirTarget; miRNATAP | -0.22 | 0 | NA | |
36 | hsa-miR-19a-3p | C10orf105 | 2.12 | 0 | -2.08 | 0 | mirMAP | -0.13 | 0.00728 | NA | |
37 | hsa-miR-19a-3p | C3orf70 | 2.12 | 0 | -1.59 | 0 | miRNATAP | -0.13 | 0.00293 | NA | |
38 | hsa-miR-19a-3p | C5orf24 | 2.12 | 0 | -0.34 | 0.00325 | mirMAP | -0.11 | 0 | NA | |
39 | hsa-miR-19a-3p | CAB39 | 2.12 | 0 | -0.11 | 0.30508 | MirTarget; miRNATAP | -0.12 | 0 | NA | |
40 | hsa-miR-19a-3p | CACNA1C | 2.12 | 0 | -1.13 | 2.0E-5 | MirTarget | -0.17 | 3.0E-5 | NA | |
41 | hsa-miR-19a-3p | CASP10 | 2.12 | 0 | -0.27 | 0.09806 | MirTarget; mirMAP | -0.1 | 6.0E-5 | NA | |
42 | hsa-miR-19a-3p | CAST | 2.12 | 0 | -0.37 | 0.00369 | miRNATAP | -0.17 | 0 | NA | |
43 | hsa-miR-19a-3p | CBX7 | 2.12 | 0 | -1.83 | 0 | mirMAP; miRNATAP | -0.15 | 1.0E-5 | NA | |
44 | hsa-miR-19a-3p | CCDC126 | 2.12 | 0 | -0.19 | 0.16106 | MirTarget; miRNATAP | -0.11 | 0 | NA | |
45 | hsa-miR-19a-3p | CCDC8 | 2.12 | 0 | -1.16 | 3.0E-5 | MirTarget | -0.11 | 0.00892 | NA | |
46 | hsa-miR-19a-3p | CCND1 | 2.12 | 0 | -0.3 | 0.2554 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.22 | 0 | 25985117 | Moreover miR-19a might play inhibitory roles in HCC malignancy via regulating Cyclin D1 expression |
47 | hsa-miR-19a-3p | CCND2 | 2.12 | 0 | -1.64 | 0 | MirTarget; miRNATAP | -0.17 | 1.0E-5 | NA | |
48 | hsa-miR-19a-3p | CCNT1 | 2.12 | 0 | -0.35 | 0.14552 | mirMAP | -0.16 | 2.0E-5 | NA | |
49 | hsa-miR-19a-3p | CCPG1 | 2.12 | 0 | -0.26 | 0.07928 | MirTarget | -0.19 | 0 | NA | |
50 | hsa-miR-19a-3p | CD164 | 2.12 | 0 | -0.08 | 0.50906 | miRNATAP | -0.14 | 0 | NA | |
51 | hsa-miR-19a-3p | CD47 | 2.12 | 0 | -0.76 | 2.0E-5 | MirTarget | -0.16 | 0 | NA | |
52 | hsa-miR-19a-3p | CD69 | 2.12 | 0 | -1.61 | 0 | miRNATAP | -0.25 | 0 | NA | |
53 | hsa-miR-19a-3p | CD84 | 2.12 | 0 | -0.48 | 0.13309 | MirTarget | -0.28 | 0 | NA | |
54 | hsa-miR-19a-3p | CDC42BPA | 2.12 | 0 | 0.13 | 0.56325 | MirTarget; miRNATAP | -0.11 | 0.00215 | NA | |
55 | hsa-miR-19a-3p | CDH13 | 2.12 | 0 | -2.32 | 0 | MirTarget | -0.24 | 0 | NA | |
56 | hsa-miR-19a-3p | CDHR1 | 2.12 | 0 | -1.19 | 0.00175 | MirTarget | -0.14 | 0.02015 | NA | |
57 | hsa-miR-19a-3p | CDKN2B | 2.12 | 0 | -1.65 | 0 | mirMAP | -0.11 | 0.02151 | NA | |
58 | hsa-miR-19a-3p | CDS1 | 2.12 | 0 | -0.26 | 0.14104 | miRNATAP | -0.12 | 3.0E-5 | NA | |
59 | hsa-miR-19a-3p | CLIP4 | 2.12 | 0 | -0.78 | 3.0E-5 | MirTarget; miRNATAP | -0.11 | 0.00032 | NA | |
60 | hsa-miR-19a-3p | CLOCK | 2.12 | 0 | 0.04 | 0.82828 | MirTarget | -0.13 | 0 | NA | |
61 | hsa-miR-19a-3p | CNKSR2 | 2.12 | 0 | -3.17 | 0 | MirTarget; miRNATAP | -0.27 | 0.00014 | NA | |
62 | hsa-miR-19a-3p | CNOT6L | 2.12 | 0 | -0.36 | 0.00099 | mirMAP | -0.12 | 0 | NA | |
63 | hsa-miR-19a-3p | CNTFR | 2.12 | 0 | -4.21 | 0 | miRNATAP | -0.17 | 0.03904 | NA | |
64 | hsa-miR-19a-3p | CPEB4 | 2.12 | 0 | -0.54 | 0.00017 | mirMAP; miRNATAP | -0.15 | 0 | NA | |
65 | hsa-miR-19a-3p | CREBL2 | 2.12 | 0 | -0.66 | 0 | miRNATAP | -0.18 | 0 | NA | |
66 | hsa-miR-19a-3p | CSF2RB | 2.12 | 0 | -1.28 | 0 | MirTarget | -0.17 | 4.0E-5 | NA | |
67 | hsa-miR-19a-3p | CTGF | 2.12 | 0 | -1.94 | 0 | MirTarget; miRNATAP | -0.25 | 0 | NA | |
68 | hsa-miR-19a-3p | CYLD | 2.12 | 0 | -0.44 | 0.00061 | miRNATAP | -0.14 | 0 | NA | |
69 | hsa-miR-19a-3p | CYP2U1 | 2.12 | 0 | -1.2 | 0 | MirTarget | -0.25 | 0 | NA | |
70 | hsa-miR-19a-3p | DAAM1 | 2.12 | 0 | -0.44 | 0.00894 | miRNATAP | -0.14 | 0 | NA | |
71 | hsa-miR-19a-3p | DCBLD2 | 2.12 | 0 | 0.33 | 0.24787 | MirTarget; mirMAP; miRNATAP | -0.11 | 0.01064 | NA | |
72 | hsa-miR-19a-3p | DKK3 | 2.12 | 0 | -1.58 | 0 | miRNATAP | -0.3 | 0 | NA | |
73 | hsa-miR-19a-3p | DLC1 | 2.12 | 0 | -2.53 | 0 | mirMAP; miRNATAP | -0.29 | 0 | NA | |
74 | hsa-miR-19a-3p | DLG2 | 2.12 | 0 | -0.4 | 0.15229 | mirMAP | -0.17 | 0.00016 | NA | |
75 | hsa-miR-19a-3p | DNAJB14 | 2.12 | 0 | -0.4 | 0.00192 | mirMAP | -0.15 | 0 | NA | |
76 | hsa-miR-19a-3p | DOCK10 | 2.12 | 0 | -0.36 | 0.1383 | miRNATAP | -0.18 | 0 | NA | |
77 | hsa-miR-19a-3p | DOK6 | 2.12 | 0 | -1.82 | 0 | mirMAP | -0.19 | 0.00027 | NA | |
78 | hsa-miR-19a-3p | DPYSL2 | 2.12 | 0 | -1.8 | 0 | miRNAWalker2 validate | -0.26 | 0 | NA | |
79 | hsa-miR-19a-3p | DSEL | 2.12 | 0 | -0.89 | 0.00132 | MirTarget; miRNATAP | -0.15 | 0.00061 | NA | |
80 | hsa-miR-19a-3p | EBF1 | 2.12 | 0 | -1.4 | 0 | miRNATAP | -0.15 | 1.0E-5 | NA | |
81 | hsa-miR-19a-3p | EEA1 | 2.12 | 0 | -0.47 | 0.00057 | mirMAP; miRNATAP | -0.15 | 0 | NA | |
82 | hsa-miR-19a-3p | EFNB2 | 2.12 | 0 | -1.34 | 0 | miRNATAP | -0.25 | 0 | NA | |
83 | hsa-miR-19a-3p | EFR3A | 2.12 | 0 | 0.12 | 0.37998 | MirTarget | -0.11 | 0 | NA | |
84 | hsa-miR-19a-3p | ELK3 | 2.12 | 0 | -0.48 | 0.01994 | MirTarget; miRNATAP | -0.25 | 0 | NA | |
85 | hsa-miR-19a-3p | ENC1 | 2.12 | 0 | 1 | 0 | MirTarget | -0.14 | 5.0E-5 | NA | |
86 | hsa-miR-19a-3p | ENDOD1 | 2.12 | 0 | 0.06 | 0.80229 | mirMAP | -0.24 | 0 | NA | |
87 | hsa-miR-19a-3p | ERBB4 | 2.12 | 0 | -3.26 | 0 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.28 | 0.00034 | NA | |
88 | hsa-miR-19a-3p | ESR1 | 2.12 | 0 | -0.26 | 0.51027 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.21 | 0.00065 | 26416600 | We speculate that miR-19a might be co-expressed with lncRNA-DLEU1 to co-regulate the expression of ESR1 which influences the occurrence and development of breast cancer cells with different levels of ER expression |
89 | hsa-miR-19a-3p | ETV1 | 2.12 | 0 | -1.79 | 0 | MirTarget; miRNATAP | -0.43 | 0 | NA | |
90 | hsa-miR-19a-3p | ETV5 | 2.12 | 0 | -1.43 | 0 | MirTarget; miRNATAP | -0.25 | 0 | NA | |
91 | hsa-miR-19a-3p | EVI5 | 2.12 | 0 | -0.65 | 0 | mirMAP | -0.11 | 0 | NA | |
92 | hsa-miR-19a-3p | F3 | 2.12 | 0 | -0.75 | 0.02302 | MirTarget; miRNATAP | -0.15 | 0.00496 | NA | |
93 | hsa-miR-19a-3p | FAM114A1 | 2.12 | 0 | 0.58 | 0.00084 | MirTarget; miRNATAP | -0.13 | 0 | NA | |
94 | hsa-miR-19a-3p | FAM155A | 2.12 | 0 | -1.07 | 0.00464 | MirTarget | -0.22 | 0.0002 | NA | |
95 | hsa-miR-19a-3p | FAM168A | 2.12 | 0 | -0.32 | 0.09708 | MirTarget; mirMAP | -0.12 | 0.00011 | NA | |
96 | hsa-miR-19a-3p | FAM46B | 2.12 | 0 | -3.17 | 0 | MirTarget; miRNATAP | -0.12 | 0.01911 | NA | |
97 | hsa-miR-19a-3p | FAM46C | 2.12 | 0 | -0.22 | 0.37961 | mirMAP; miRNATAP | -0.18 | 0 | NA | |
98 | hsa-miR-19a-3p | FAT3 | 2.12 | 0 | -3.31 | 0 | mirMAP; miRNATAP | -0.17 | 0.01455 | NA | |
99 | hsa-miR-19a-3p | FBXL7 | 2.12 | 0 | -1.42 | 0 | mirMAP | -0.16 | 0 | NA | |
100 | hsa-miR-19a-3p | FBXO8 | 2.12 | 0 | -0.44 | 2.0E-5 | MirTarget; miRNATAP | -0.13 | 0 | NA | |
101 | hsa-miR-19a-3p | FBXW11 | 2.12 | 0 | -0.3 | 0.01022 | MirTarget | -0.14 | 0 | NA | |
102 | hsa-miR-19a-3p | FEM1C | 2.12 | 0 | -0.53 | 6.0E-5 | miRNATAP | -0.15 | 0 | NA | |
103 | hsa-miR-19a-3p | FIBIN | 2.12 | 0 | -2.56 | 0 | MirTarget | -0.31 | 0 | NA | |
104 | hsa-miR-19a-3p | FOXF2 | 2.12 | 0 | -1.7 | 0 | miRNATAP | -0.35 | 0 | NA | |
105 | hsa-miR-19a-3p | FOXP1 | 2.12 | 0 | -0.66 | 1.0E-5 | MirTarget; mirMAP; miRNATAP | -0.14 | 0 | 26367773 | The four miR-19a target cDNA expression vectors suppressed cell viability colony formation migration and invasion of A549 and LK79 cells but LK79 cells transfected with FOXP1 and TP53INP1 cDNAs showed no difference compared to the control cells in the invasion assay |
106 | hsa-miR-19a-3p | G3BP2 | 2.12 | 0 | -0.04 | 0.75462 | MirTarget; miRNATAP | -0.1 | 0 | NA | |
107 | hsa-miR-19a-3p | GAS7 | 2.12 | 0 | -1.49 | 0 | mirMAP | -0.27 | 0 | NA | |
108 | hsa-miR-19a-3p | GIMAP6 | 2.12 | 0 | -2.32 | 0 | mirMAP | -0.26 | 0 | NA | |
109 | hsa-miR-19a-3p | GJA1 | 2.12 | 0 | -1.74 | 0 | MirTarget; miRNATAP | -0.22 | 1.0E-5 | NA | |
110 | hsa-miR-19a-3p | GLIPR1 | 2.12 | 0 | -0.68 | 0.00145 | mirMAP | -0.22 | 0 | NA | |
111 | hsa-miR-19a-3p | GLIS3 | 2.12 | 0 | -0.08 | 0.7529 | mirMAP | -0.19 | 0 | NA | |
112 | hsa-miR-19a-3p | GNAQ | 2.12 | 0 | -1.17 | 0 | MirTarget; mirMAP | -0.18 | 0 | NA | |
113 | hsa-miR-19a-3p | GPM6B | 2.12 | 0 | -2.41 | 0 | mirMAP | -0.1 | 0.03166 | NA | |
114 | hsa-miR-19a-3p | GTF2A1 | 2.12 | 0 | -0.14 | 0.4882 | MirTarget; miRNATAP | -0.2 | 0 | NA | |
115 | hsa-miR-19a-3p | GZMK | 2.12 | 0 | -0.03 | 0.92425 | MirTarget | -0.14 | 0.01715 | NA | |
116 | hsa-miR-19a-3p | HBP1 | 2.12 | 0 | -0.42 | 0.00016 | MirTarget; miRNATAP | -0.13 | 0 | NA | |
117 | hsa-miR-19a-3p | HCFC2 | 2.12 | 0 | -0.62 | 0 | MirTarget | -0.14 | 0 | NA | |
118 | hsa-miR-19a-3p | HEG1 | 2.12 | 0 | -2.36 | 0 | mirMAP; miRNATAP | -0.23 | 0 | NA | |
119 | hsa-miR-19a-3p | HIP1 | 2.12 | 0 | -0.83 | 0.00018 | MirTarget | -0.22 | 0 | NA | |
120 | hsa-miR-19a-3p | HIPK1 | 2.12 | 0 | -0.53 | 2.0E-5 | MirTarget; mirMAP; miRNATAP | -0.12 | 0 | NA | |
121 | hsa-miR-19a-3p | HIPK3 | 2.12 | 0 | -1.01 | 0 | MirTarget; miRNATAP | -0.26 | 0 | NA | |
122 | hsa-miR-19a-3p | HLF | 2.12 | 0 | -2.49 | 0 | miRNATAP | -0.39 | 0 | NA | |
123 | hsa-miR-19a-3p | HOXA5 | 2.12 | 0 | -1.79 | 0 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.14 | 0.00058 | NA | |
124 | hsa-miR-19a-3p | ICOS | 2.12 | 0 | -1.03 | 0.001 | mirMAP | -0.12 | 0.01471 | NA | |
125 | hsa-miR-19a-3p | IGF1 | 2.12 | 0 | -0.88 | 0.00545 | MirTarget | -0.3 | 0 | NA | |
126 | hsa-miR-19a-3p | IGF2 | 2.12 | 0 | -1.09 | 0.0418 | mirMAP | -0.17 | 0.04576 | NA | |
127 | hsa-miR-19a-3p | IKZF1 | 2.12 | 0 | -0.95 | 0.00018 | mirMAP | -0.22 | 0 | NA | |
128 | hsa-miR-19a-3p | IL1RAP | 2.12 | 0 | 0 | 0.99919 | MirTarget | -0.2 | 0 | NA | |
129 | hsa-miR-19a-3p | IL6ST | 2.12 | 0 | -1.4 | 0 | mirMAP; miRNATAP | -0.38 | 0 | NA | |
130 | hsa-miR-19a-3p | IPCEF1 | 2.12 | 0 | 0.31 | 0.35323 | mirMAP | -0.22 | 3.0E-5 | NA | |
131 | hsa-miR-19a-3p | ITGA2 | 2.12 | 0 | 0.82 | 0.02366 | MirTarget | -0.25 | 1.0E-5 | NA | |
132 | hsa-miR-19a-3p | ITGB8 | 2.12 | 0 | 0.34 | 0.46013 | MirTarget | -0.29 | 6.0E-5 | NA | |
133 | hsa-miR-19a-3p | ITPR1 | 2.12 | 0 | -1.22 | 0 | MirTarget; miRNATAP | -0.16 | 1.0E-5 | NA | |
134 | hsa-miR-19a-3p | JAM2 | 2.12 | 0 | -2.67 | 0 | miRNATAP | -0.25 | 0 | NA | |
135 | hsa-miR-19a-3p | JAZF1 | 2.12 | 0 | -0.97 | 0 | MirTarget | -0.19 | 0 | NA | |
136 | hsa-miR-19a-3p | KAT2B | 2.12 | 0 | -1.27 | 0 | miRNAWalker2 validate | -0.23 | 0 | NA | |
137 | hsa-miR-19a-3p | KBTBD11 | 2.12 | 0 | -0.82 | 0.00476 | mirMAP | -0.16 | 0.00059 | NA | |
138 | hsa-miR-19a-3p | KBTBD8 | 2.12 | 0 | -0.82 | 0.00029 | MirTarget | -0.18 | 0 | NA | |
139 | hsa-miR-19a-3p | KCNA1 | 2.12 | 0 | -0.61 | 0.22469 | mirMAP | -0.23 | 0.0037 | NA | |
140 | hsa-miR-19a-3p | KCNA4 | 2.12 | 0 | -5.11 | 0 | MirTarget; miRNATAP | -0.41 | 0 | NA | |
141 | hsa-miR-19a-3p | KCNJ2 | 2.12 | 0 | -1.33 | 0 | MirTarget; miRNATAP | -0.16 | 0.00026 | NA | |
142 | hsa-miR-19a-3p | KCNJ5 | 2.12 | 0 | -2.49 | 0 | mirMAP | -0.33 | 0 | NA | |
143 | hsa-miR-19a-3p | KCNQ5 | 2.12 | 0 | 1.52 | 0.0012 | MirTarget | -0.19 | 0.00934 | NA | |
144 | hsa-miR-19a-3p | KCTD12 | 2.12 | 0 | -1.56 | 0 | mirMAP | -0.3 | 0 | NA | |
145 | hsa-miR-19a-3p | KIAA0513 | 2.12 | 0 | -0.71 | 0.00012 | mirMAP | -0.1 | 0.00034 | NA | |
146 | hsa-miR-19a-3p | KIAA2022 | 2.12 | 0 | -0.86 | 0.09254 | mirMAP | -0.3 | 0.00018 | NA | |
147 | hsa-miR-19a-3p | KIF6 | 2.12 | 0 | -1.88 | 2.0E-5 | mirMAP | -0.18 | 0.00794 | NA | |
148 | hsa-miR-19a-3p | KITLG | 2.12 | 0 | -0.41 | 0.09469 | mirMAP | -0.18 | 0 | NA | |
149 | hsa-miR-19a-3p | KLF10 | 2.12 | 0 | -1 | 0 | miRNATAP | -0.13 | 0 | NA | |
150 | hsa-miR-19a-3p | KLF13 | 2.12 | 0 | -1.61 | 0 | miRNATAP | -0.13 | 1.0E-5 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL DEVELOPMENT | 66 | 1426 | 5.657e-13 | 2.632e-09 |
2 | POSITIVE REGULATION OF GENE EXPRESSION | 68 | 1733 | 3.853e-10 | 8.965e-07 |
3 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 65 | 1672 | 1.49e-09 | 2.31e-06 |
4 | TISSUE DEVELOPMENT | 60 | 1518 | 3.889e-09 | 4.523e-06 |
5 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 66 | 1805 | 1.253e-08 | 1.043e-05 |
6 | REGULATION OF CELL DIFFERENTIATION | 58 | 1492 | 1.344e-08 | 1.043e-05 |
7 | NEUROGENESIS | 55 | 1402 | 2.496e-08 | 1.588e-05 |
8 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 48 | 1142 | 2.73e-08 | 1.588e-05 |
9 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 44 | 1004 | 3.35e-08 | 1.732e-05 |
10 | MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 14 | 8.12e-08 | 3.778e-05 |
11 | REGULATION OF CELL PROLIFERATION | 56 | 1496 | 8.965e-08 | 3.792e-05 |
12 | NEURON DIFFERENTIATION | 39 | 874 | 1.36e-07 | 5.273e-05 |
13 | NEGATIVE REGULATION OF CELL PROLIFERATION | 32 | 643 | 1.798e-07 | 6.434e-05 |
14 | SKELETAL SYSTEM DEVELOPMENT | 26 | 455 | 1.978e-07 | 6.576e-05 |
15 | EPITHELIAL CELL DEVELOPMENT | 16 | 186 | 2.365e-07 | 6.878e-05 |
16 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 62 | 1784 | 2.332e-07 | 6.878e-05 |
17 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 62 | 1791 | 2.674e-07 | 7.318e-05 |
18 | EPITHELIAL CELL DIFFERENTIATION | 27 | 495 | 2.893e-07 | 7.479e-05 |
19 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 35 | 788 | 6.941e-07 | 0.0001615 |
20 | CIRCULATORY SYSTEM DEVELOPMENT | 35 | 788 | 6.941e-07 | 0.0001615 |
21 | REGULATION OF TRANSPORT | 61 | 1804 | 7.537e-07 | 0.000167 |
22 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 19 | 285 | 9.417e-07 | 0.0001969 |
23 | MUSCLE STRUCTURE DEVELOPMENT | 24 | 432 | 9.735e-07 | 0.0001969 |
24 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 53 | 1518 | 1.766e-06 | 0.0003285 |
25 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 50 | 1395 | 1.718e-06 | 0.0003285 |
26 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 26 | 513 | 1.906e-06 | 0.0003285 |
27 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 35 | 823 | 1.867e-06 | 0.0003285 |
28 | NEGATIVE REGULATION OF GENE EXPRESSION | 52 | 1493 | 2.408e-06 | 0.0003863 |
29 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 32 | 724 | 2.368e-06 | 0.0003863 |
30 | EPITHELIUM DEVELOPMENT | 38 | 945 | 2.515e-06 | 0.0003901 |
31 | REGULATION OF ION TRANSPORT | 28 | 592 | 2.909e-06 | 0.0004366 |
32 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 21 | 368 | 3.086e-06 | 0.0004487 |
33 | NEURON PROJECTION MORPHOGENESIS | 22 | 402 | 3.539e-06 | 0.0004843 |
34 | CARDIAC MUSCLE CELL ACTION POTENTIAL | 7 | 37 | 3.47e-06 | 0.0004843 |
35 | CELL COMMUNICATION BY ELECTRICAL COUPLING | 5 | 15 | 4.505e-06 | 0.000599 |
36 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 51 | 1492 | 5.179e-06 | 0.0006648 |
37 | CELLULAR COMPONENT MORPHOGENESIS | 36 | 900 | 5.287e-06 | 0.0006648 |
38 | TUBE DEVELOPMENT | 26 | 552 | 7.138e-06 | 0.0008741 |
39 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 39 | 1036 | 8.716e-06 | 0.001014 |
40 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 39 | 1036 | 8.716e-06 | 0.001014 |
41 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 54 | 1656 | 1.033e-05 | 0.001152 |
42 | INTRACELLULAR SIGNAL TRANSDUCTION | 52 | 1572 | 1.04e-05 | 0.001152 |
43 | RESPONSE TO ENDOGENOUS STIMULUS | 49 | 1450 | 1.102e-05 | 0.001176 |
44 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 53 | 1618 | 1.112e-05 | 0.001176 |
45 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 41 | 1135 | 1.347e-05 | 0.001392 |
46 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 38 | 1021 | 1.477e-05 | 0.001494 |
47 | NEURON DEVELOPMENT | 29 | 687 | 1.697e-05 | 0.001678 |
48 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 50 | 1517 | 1.731e-05 | 0.001678 |
49 | HEART PROCESS | 9 | 85 | 2.031e-05 | 0.001928 |
50 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 31 | 771 | 2.223e-05 | 0.002068 |
51 | MUSCLE CELL DIFFERENTIATION | 15 | 237 | 2.437e-05 | 0.002224 |
52 | REGULATION OF PROTEIN MODIFICATION PROCESS | 54 | 1710 | 2.53e-05 | 0.002247 |
53 | RESPONSE TO MECHANICAL STIMULUS | 14 | 210 | 2.559e-05 | 0.002247 |
54 | VASCULATURE DEVELOPMENT | 22 | 469 | 3.877e-05 | 0.00334 |
55 | NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 10 | 115 | 4.006e-05 | 0.003389 |
56 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 43 | 1275 | 4.208e-05 | 0.003496 |
57 | NEURON PROJECTION DEVELOPMENT | 24 | 545 | 4.744e-05 | 0.003687 |
58 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 28 | 689 | 4.651e-05 | 0.003687 |
59 | ORGAN MORPHOGENESIS | 32 | 841 | 4.754e-05 | 0.003687 |
60 | ACTION POTENTIAL | 9 | 94 | 4.56e-05 | 0.003687 |
61 | GROWTH | 20 | 410 | 5.079e-05 | 0.003874 |
62 | REGULATION OF POSITIVE CHEMOTAXIS | 5 | 24 | 5.589e-05 | 0.004194 |
63 | REGULATION OF PEPTIDE TRANSPORT | 15 | 256 | 5.917e-05 | 0.004302 |
64 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 36 | 1008 | 5.897e-05 | 0.004302 |
65 | MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 6 | 39 | 6.058e-05 | 0.004316 |
66 | RELAXATION OF CARDIAC MUSCLE | 4 | 13 | 6.215e-05 | 0.004316 |
67 | POSITIVE REGULATION OF CELL PROLIFERATION | 31 | 814 | 6.16e-05 | 0.004316 |
68 | REGULATION OF CELL PROJECTION ORGANIZATION | 24 | 558 | 6.853e-05 | 0.004689 |
69 | MULTICELLULAR ORGANISMAL SIGNALING | 10 | 123 | 7.112e-05 | 0.004796 |
70 | NEURON PROJECTION GUIDANCE | 13 | 205 | 8.27e-05 | 0.005497 |
71 | REGULATION OF TRANSMEMBRANE TRANSPORT | 20 | 426 | 8.592e-05 | 0.005631 |
72 | REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 13 | 207 | 9.124e-05 | 0.005896 |
73 | LOCOMOTION | 38 | 1114 | 9.574e-05 | 0.005966 |
74 | REGULATION OF CHEMOTAXIS | 12 | 180 | 9.617e-05 | 0.005966 |
75 | GLAND DEVELOPMENT | 19 | 395 | 9.388e-05 | 0.005966 |
76 | HEART DEVELOPMENT | 21 | 466 | 0.0001022 | 0.006258 |
77 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 33 | 917 | 0.0001051 | 0.00635 |
78 | DEVELOPMENTAL GROWTH | 17 | 333 | 0.0001072 | 0.006392 |
79 | POSITIVE REGULATION OF MAPK CASCADE | 21 | 470 | 0.0001151 | 0.006781 |
80 | POSITIVE REGULATION OF OSSIFICATION | 8 | 84 | 0.0001252 | 0.007281 |
81 | REGULATION OF MAPK CASCADE | 26 | 660 | 0.0001431 | 0.008137 |
82 | RESPONSE TO HORMONE | 32 | 893 | 0.0001448 | 0.008137 |
83 | CARDIAC MUSCLE CELL CONTRACTION | 5 | 29 | 0.0001451 | 0.008137 |
84 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 28 | 740 | 0.0001564 | 0.008665 |
85 | REGULATION OF HOMEOSTATIC PROCESS | 20 | 447 | 0.0001639 | 0.008971 |
86 | LENS DEVELOPMENT IN CAMERA TYPE EYE | 7 | 66 | 0.0001687 | 0.009128 |
87 | OSSIFICATION | 14 | 251 | 0.000174 | 0.009201 |
88 | CELL PROJECTION ORGANIZATION | 32 | 902 | 0.0001735 | 0.009201 |
89 | CELL PART MORPHOGENESIS | 25 | 633 | 0.0001846 | 0.009575 |
90 | REGULATION OF CELL JUNCTION ASSEMBLY | 7 | 68 | 0.0002037 | 0.009575 |
91 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 28 | 750 | 0.0001951 | 0.009575 |
92 | CELL PROLIFERATION | 26 | 672 | 0.00019 | 0.009575 |
93 | ENDOTHELIUM DEVELOPMENT | 8 | 90 | 0.000203 | 0.009575 |
94 | ORGAN GROWTH | 7 | 68 | 0.0002037 | 0.009575 |
95 | MAMMARY GLAND ALVEOLUS DEVELOPMENT | 4 | 17 | 0.0001955 | 0.009575 |
96 | CONNECTIVE TISSUE DEVELOPMENT | 12 | 194 | 0.0001946 | 0.009575 |
97 | MAMMARY GLAND LOBULE DEVELOPMENT | 4 | 17 | 0.0001955 | 0.009575 |
98 | POST EMBRYONIC DEVELOPMENT | 8 | 89 | 0.0001878 | 0.009575 |
99 | BIOLOGICAL ADHESION | 35 | 1032 | 0.0002037 | 0.009575 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | REGULATORY REGION NUCLEIC ACID BINDING | 35 | 818 | 1.628e-06 | 0.0007562 |
2 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 20 | 315 | 1.045e-06 | 0.0007562 |
3 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 29 | 629 | 3.177e-06 | 0.0009837 |
4 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 19 | 328 | 7.376e-06 | 0.00137 |
5 | LIPID BINDING | 29 | 657 | 7.347e-06 | 0.00137 |
6 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 43 | 1199 | 9.732e-06 | 0.001507 |
7 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 15 | 226 | 1.393e-05 | 0.001849 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 58 | 1649 | 4.151e-07 | 0.0002345 |
2 | ENDOSOME | 35 | 793 | 8.03e-07 | 0.0002345 |
3 | EARLY ENDOSOME | 19 | 301 | 2.123e-06 | 0.0004133 |
4 | NEURON PART | 45 | 1265 | 7.29e-06 | 0.001064 |
5 | VACUOLE | 41 | 1180 | 3.301e-05 | 0.003298 |
6 | NEURON PROJECTION | 35 | 942 | 3.388e-05 | 0.003298 |
7 | T TUBULE | 6 | 45 | 0.0001383 | 0.008971 |
8 | SOMATODENDRITIC COMPARTMENT | 26 | 650 | 0.0001122 | 0.008971 |
9 | PLASMA MEMBRANE PROTEIN COMPLEX | 22 | 510 | 0.0001317 | 0.008971 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | MAPK_signaling_pathway_hsa04010 | 17 | 295 | 2.381e-05 | 0.001238 | |
2 | Cellular_senescence_hsa04218 | 10 | 160 | 0.0006047 | 0.007621 | |
3 | cGMP_PKG_signaling_pathway_hsa04022 | 10 | 163 | 0.0006987 | 0.007621 | |
4 | Apelin_signaling_pathway_hsa04371 | 9 | 137 | 0.0007883 | 0.007621 | |
5 | Focal_adhesion_hsa04510 | 11 | 199 | 0.0009128 | 0.007621 | |
6 | Tight_junction_hsa04530 | 10 | 170 | 0.0009653 | 0.007621 | |
7 | Rap1_signaling_pathway_hsa04015 | 11 | 206 | 0.001208 | 0.007621 | |
8 | Wnt_signaling_pathway_hsa04310 | 9 | 146 | 0.001237 | 0.007621 | |
9 | p53_signaling_pathway_hsa04115 | 6 | 68 | 0.001319 | 0.007621 | |
10 | Oocyte_meiosis_hsa04114 | 8 | 124 | 0.001713 | 0.008905 | |
11 | FoxO_signaling_pathway_hsa04068 | 8 | 132 | 0.002536 | 0.01199 | |
12 | ECM_receptor_interaction_hsa04512 | 6 | 82 | 0.00343 | 0.01394 | |
13 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 8 | 139 | 0.003485 | 0.01394 | |
14 | Gap_junction_hsa04540 | 6 | 88 | 0.00486 | 0.01805 | |
15 | Phagosome_hsa04145 | 8 | 152 | 0.005955 | 0.02064 | |
16 | Hippo_signaling_pathway_hsa04390 | 8 | 154 | 0.00643 | 0.0209 | |
17 | Hedgehog_signaling_pathway_hsa04340 | 4 | 47 | 0.009642 | 0.02949 | |
18 | Cell_adhesion_molecules_.CAMs._hsa04514 | 7 | 145 | 0.01526 | 0.04408 | |
19 | TGF_beta_signaling_pathway_hsa04350 | 5 | 84 | 0.01707 | 0.04673 | |
20 | mTOR_signaling_pathway_hsa04150 | 7 | 151 | 0.01865 | 0.04716 | |
21 | Sphingolipid_signaling_pathway_hsa04071 | 6 | 118 | 0.01905 | 0.04716 | |
22 | Ras_signaling_pathway_hsa04014 | 9 | 232 | 0.02358 | 0.05573 | |
23 | Autophagy_animal_hsa04140 | 6 | 128 | 0.02711 | 0.06129 | |
24 | Calcium_signaling_pathway_hsa04020 | 7 | 182 | 0.04473 | 0.09692 | |
25 | PI3K_Akt_signaling_pathway_hsa04151 | 11 | 352 | 0.05136 | 0.1068 | |
26 | cAMP_signaling_pathway_hsa04024 | 7 | 198 | 0.06448 | 0.129 | |
27 | Jak_STAT_signaling_pathway_hsa04630 | 6 | 162 | 0.07008 | 0.135 | |
28 | Phosphatidylinositol_signaling_system_hsa04070 | 4 | 99 | 0.1005 | 0.1866 | |
29 | Cytokine_cytokine_receptor_interaction_hsa04060 | 8 | 270 | 0.1106 | 0.1983 | |
30 | Ferroptosis_hsa04216 | 2 | 40 | 0.159 | 0.2755 | |
31 | ABC_transporters_hsa02010 | 2 | 45 | 0.1908 | 0.3201 | |
32 | Apoptosis_hsa04210 | 4 | 138 | 0.2317 | 0.3765 | |
33 | TNF_signaling_pathway_hsa04668 | 3 | 108 | 0.3021 | 0.476 | |
34 | AMPK_signaling_pathway_hsa04152 | 3 | 121 | 0.3654 | 0.5487 | |
35 | Lysosome_hsa04142 | 3 | 123 | 0.375 | 0.5487 | |
36 | Cell_cycle_hsa04110 | 3 | 124 | 0.3799 | 0.5487 | |
37 | Peroxisome_hsa04146 | 2 | 83 | 0.4364 | 0.5829 | |
38 | ErbB_signaling_pathway_hsa04012 | 2 | 85 | 0.4484 | 0.5829 | |
39 | Endocytosis_hsa04144 | 4 | 244 | 0.6342 | 0.7852 | |
40 | Regulation_of_actin_cytoskeleton_hsa04810 | 3 | 208 | 0.7191 | 0.8146 | |
41 | Phospholipase_D_signaling_pathway_hsa04072 | 2 | 146 | 0.7363 | 0.8146 | |
42 | Necroptosis_hsa04217 | 2 | 164 | 0.7924 | 0.8584 |